OPCH
Option Care Health, Inc.32.93
-0.61-1.82%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
5.34BP/E (TTM)
26.13Basic EPS (TTM)
1.26Dividend Yield
0%Recent Filings
10-Q
8-K
8-K
CFO Transition Announced
Option Care Health appointed Meenal Sethna as EVP and CFO effective October 1, 2025, succeeding Mike Shapiro, who steps down after a decade but stays on as special advisor through March 31, 2026. Sethna brings 30 years of finance experience from Littelfuse and Illinois Tool Works, with a $655,000 base salary, 90% target bonus, and $2.4 million annual equity target, plus a $1.5 million sign-on RSU. Shapiro's pay drops to $246,000 during transition. This leadership shift bolsters financial strategy amid strong momentum.
10-Q
Q2 FY2025 results
Option Care Health posted solid Q2 revenue of $1.4B, up 15.4% year-over-year and 8.7% quarter-over-quarter (derived), fueled by mid-teens organic growth in acute and chronic therapies amid shifting competition, though gross margins dipped to 19.0% from 20.3% due to pricier rare disease mixes and slimmer procurement spreads. Operating income rose 2.5% y/y to $82.7M, with diluted EPS steady at $0.31 on 164M shares, reconciling cleanly without dilution flags. The January 2025 Intramed Plus buyout closed for $117.2M cash, adding $65.6M goodwill and $45.1M intangibles amortized over 15 years for procurement synergies. Cash fell to $198.8M after $83.1M operating inflows minus $18.5M capex and $150M buybacks, yet $395.9M revolver availability bolsters liquidity against $1.1B debt at blended 5.5% rates. Acquisitions expand reach smartly. Reimbursement tweaks from payers pose ongoing pressure.
8-K
Q2 revenue surges 15.4%
Option Care Health reported Q2 2025 net revenue of $1,416.1 million, up 15.4% from $1,227.2 million last year, while gross profit rose 7.9% to $269.0 million despite a dip to 19.0% margin. Net income edged down to $50.5 million from $53.0 million, but adjusted EBITDA climbed 5.2% to $114.0 million. The company repurchased $50.0 million in stock. It raised full-year guidance to $5.50-$5.65 billion in revenue, signaling resilience amid market pressures.
IPO
Employees
Sector
Industry
ACHC
Acadia Healthcare Company, Inc.
14.43+0.21
ADUS
Addus HomeCare Corporation
113.49-1.65
EHAB
Enhabit, Inc.
9.61-0.08
EHC
Encompass Health Corporation
108.01+0.42
FCHS
First Choice Healthcare Solutio
0.01+0.00
HCA
HCA Healthcare, Inc.
469.79-7.19
HCSG
Healthcare Services Group, Inc.
19.09-0.27
NHC
National HealthCare Corporation
138.93-0.94
OPK
Opko Health, Inc.
1.31-0.04
USPH
U.S. Physical Therapy, Inc.
78.50-2.65